drugset / Trial / NCT03162432
High Dose Interval Vitamin D Supplementation in Patients With IBD Receiving Remicade
NaSingle-groupOpen-labelTreatment
Summary
The goal of this study will be to assess the safety and efficacy of high-dose interval Vitamin D3 therapy in children and young adults with Inflammatory Bowel Disease being treated with serial Remicade infusions.
Timeline
- Start
- 2017-08-01
- Primary completion
- 2023-12-01
- Completion
- 2023-12-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cholecalciferol | Other / unclassified | 50000 iu | Oral |
| Subject | Cholecalciferol | Other / unclassified | 100000 iu | Oral |